The Board of Dawnrays Pharmaceutical (Holdings) Limited announced that Mr. Pan Xue Tian will retire as an independent non-executive director. Following Mr. Pan's retirement, he will cease to act as the chairman of the remuneration Committee, a member of each of the audit committee and the nomination committee of the company; and Mr. EDE, Ronald Hao Xi, a non-executive director of the company, will be re-designated as an independent non-executive director of the company, the chairman of the remuneration committee, a member of each of the audit committee and the nomination committee, with effect from 1 July 2017.